Skip to main content

MoneyWorks4Me

Laurus Labs informs about company updates

17 May 2017 Evaluate

As per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirement) regulations, 2015, Laurus Labs has informed about the Standalone and Consolidated Audited Financial results of the Company for the quarter and year ended 31.03.2017; Auditors Report on the Standalone and Consolidated Audited Financial results of the Company for the quarter and year ended 31.03.2017; and Declaration regarding audit report with unmodified opinion for the financial year ended 31.03.2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1365.10
Cipla 1403.00
Lupin 1983.90
Zydus Lifesciences 1199.00
View more..